BCL2 and gastric cancer: The results of qRT-PCR confirmed that 25 μM evodiamine could upregulate the expression of proapoptotic Bax and downregulate the antiapoptotic Bcl-2 in gastric cancer cells, resulting in the upregulation of Bax/Bcl-2 ratio.